20056-72-8

Basic information

• Product Name: 3-Undecylphenol
• Synonyms: 3-Undecylphenol
• CAS NO: 20056-72-8
• Molecular Formula: C₁₇H₂₈O
• Molecular Weight: 248.4
• Mol File: 20056-72-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Undecylphenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Undecylphenol(20056-72-8)
• EPA Substance Registry System: 3-Undecylphenol(20056-72-8)

Safety Data

• Hazardous Substances Data: 20056-72-8(Hazardous Substances Data)

Upstream product

• 156668-96-1 1-[3-(phenylmethoxy)phenyl]undecanol 
• 702660-65-9 1-(3-hydroxyphenyl)undec-1-ene 
• 135454-93-2 3-undecylcyclohex-2-en-1-one 
• 117286-10-9 undecylmagnesium bromide 
• 112-29-8 1-bromo dodecane 
• 32339-43-8 decyltriphenylphosphonium bromide 
• 603-35-0 triphenylphosphine 
• 1700-37-4 3-Benzyloxybenzaldehyde 
• 133910-12-0 (1,1-dimethylethyl)(3-iodophenoxy)dimethylsilane 
• 2243-98-3 1-undecyne 

Downstream Products

• 52431-54-6 2-undecyl-1,4-benzoquinone 
• 15071-57-5 Methyl 3-n-pentadecylphenyl ether 
• 20056-63-7 3-undecyl phenol monomethyl ether 
• 22161-93-9 3-tridecyl methoxybenzene 
• 702660-67-1 2-hydroxy-4-n-undecylbenzaldehyde 
• 894071-20-6 C₃₄H₅₄O₂S 
• 894071-24-0 di(4-hydroxy-2-n-undecylphenyl)sulphide 

Relevant articles and documents

Design, synthesis, and structure–activity relationship studies of the anaephene antibiotics

The natural products, anaephenes A (1) and B (2), were found to have antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). In this report, we expanded on our previous synthetic efforts by preparing a library of eighteen analogues in order to understand the structure–activity relationships (SAR) of this interesting class of natural products. These analogues were selected to explore the biological impact of structural variations in the alkyl chain and on the phenol moiety. Last, we further assessed the biological activity of anaephene B (2) and two additional analogues against other clinically relevant bacterial strains and the hemolytic activity of each and determined that these compounds act via a bactericidal mechanism. These studies led to the identification of compound 7, which was 4-fold more potent than the natural product (2) against MRSA (2 vs. 8?μg/ml) and a 2-hydroxypyridine analogue (18) which demonstrated equal potency compared with the natural product (2), albeit with a significant reduction in hemolytic activity (1% vs. 80% at 100?μM).

The separation and synthesis of lipidic 1,2- and 1,3-diols from natural phenolic lipids for the complexation and recovery of boron

A study has been made of the semi-synthesis of 1,3-diols (anacardic alcohols) from natural phenolic lipid resources from Anacardium occidentale and Anacardium giganteum which have given C15 and C11 derivatives, respectively. An isomeric 1,3-diol (isoanacardic alcohol) has been obtained from cardanol separated from technical cashew nut-shell liquid. Homologous1,3-diols have been synthesised from a range of synthetic 2-alkyl-, 3-alkyl- and 4-alkylphenols and from 6-alkylsalicylic acids. The natural 1,2-diol, urushiol, from Rhus vernicifera has been purified. All these lipidic compounds have been studied for their complexation and the potential recovery of boron as boric acid.

A quantitative structure-activity relationship for antitumor activity of long-chain phenols from Ginkgo biloba L.

-